91 related articles for article (PubMed ID: 34593610)
1. Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4-LEF1 Binding.
Lanauze CB; Sehgal P; Hayer K; Torres-Diz M; Pippin JA; Grant SFA; Thomas-Tikhonenko A
Mol Cancer Res; 2021 May; 19(5):823-833. PubMed ID: 33608451
[TBL] [Abstract][Full Text] [Related]
2. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner.
Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X
Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Wnt/β-catenin signaling pathway and CTNNB1 mutations in canine intestinal epithelial proliferative lesions.
Ishikawa K; Chambers JK; Uchida K
J Vet Med Sci; 2024 May; ():. PubMed ID: 38811188
[TBL] [Abstract][Full Text] [Related]
4. ICBP90, an epigenetic regulator, induces DKK3 promoter methylation, promotes glioma progression, and reduces sensitivity to cis-platinum.
Cao Q; Wang X; Liu J; Dong Y; Wu X; Mi Y; Liu K; Zhang M; Shi Y; Fan R
Exp Cell Res; 2024 Mar; 436(2):113976. PubMed ID: 38401687
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin ligase HUWE1 enhances WNT signaling by antagonizing destruction complex-mediated β-catenin degradation and through a mechanism independent of β-catenin stability.
McKenna JK; Wu Y; Sonkusre P; Chari R; Lebensohn AM
bioRxiv; 2024 Mar; ():. PubMed ID: 38410441
[TBL] [Abstract][Full Text] [Related]
6. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
[TBL] [Abstract][Full Text] [Related]
7. α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer.
Tran TQ; Hanse EA; Habowski AN; Li H; Ishak Gabra MB; Yang Y; Lowman XH; Ooi AM; Liao SY; Edwards RA; Waterman ML; Kong M
Nat Cancer; 2020 Mar; 1(3):345-358. PubMed ID: 32832918
[TBL] [Abstract][Full Text] [Related]
8. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder.
Nagy N; Pál M; Nagy D; Bokor BA; Zimmermann A; Gellén B; Salamon A; Sztriha L; Klivényi P; Széll M
BMC Pediatr; 2024 Jan; 24(1):47. PubMed ID: 38225558
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms.
Park MA; Zaw T; Yoder SJ; Gomez M; Genilo-Delgado M; Basinski T; Katende E; Dam A; Mok SRS; Monteiro A; Mohammadi A; Jeong DK; Jiang K; Centeno BA; Hodul P; Malafa M; Fleming J; Chen DT; Mo Q; Teer JK; Permuth JB
G3 (Bethesda); 2023 Feb; 13(2):. PubMed ID: 36454217
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR92a Promotes Cytarabine Resistance in Myelodysplastic Syndromes by Activating Wnt/β-catenin Signal Pathway.
Li H; Xie C; Lu Y; Chang K; Guan F; Li X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291656
[TBL] [Abstract][Full Text] [Related]
11. Drug-Resistant Stem Cells: Novel Approach for Colon Cancer Therapy.
Telang N
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269660
[TBL] [Abstract][Full Text] [Related]
12. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer.
Yao J; Li G; Liu M; Yang S; Su H; Ye C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
14. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
[No Abstract] [Full Text] [Related]
15. [In situ analyses of molecular mechanisms of colorectal carcinogenesis].
Kriegl L
Pathologe; 2013 Nov; 34 Suppl 2():269-73. PubMed ID: 24196627
[TBL] [Abstract][Full Text] [Related]
16. Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention.
Kelson CO; Zaytseva YY
Front Oncol; 2024; 14():1343061. PubMed ID: 38590663
[TBL] [Abstract][Full Text] [Related]
17. MYC Hyperactivates Wnt Signaling in
Sehgal P; Lanauze C; Wang X; Hayer KE; Torres-Diz M; Leu NA; Sela Y; Stanger BZ; Lengner CJ; Thomas-Tikhonenko A
Mol Cancer Res; 2021 Dec; 19(12):2003-2014. PubMed ID: 34593610
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
